Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study.
about
Jacalin-Activated Macrophages Exhibit an Antitumor PhenotypeAviscumine, a recombinant ribosomal inhibitor, increases the antitumor activity of natural killer cells.Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice
P2860
Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Treatment of unresectable stag ...... phase II, multi-centre study.
@ast
Treatment of unresectable stag ...... phase II, multi-centre study.
@en
Treatment of unresectable stag ...... phase II, multi-centre study.
@nl
type
label
Treatment of unresectable stag ...... phase II, multi-centre study.
@ast
Treatment of unresectable stag ...... phase II, multi-centre study.
@en
Treatment of unresectable stag ...... phase II, multi-centre study.
@nl
prefLabel
Treatment of unresectable stag ...... phase II, multi-centre study.
@ast
Treatment of unresectable stag ...... phase II, multi-centre study.
@en
Treatment of unresectable stag ...... phase II, multi-centre study.
@nl
P2093
P2860
P1476
Treatment of unresectable stag ...... phase II, multi-centre study.
@en
P2093
Florian Schenck
Hans Lentzen
Katharina C Kähler
Klaus Witthohn
Peter Mohr
Ralf Gutzmer
Tabea Wilhelm
Uwe Trefzer
Volkmar Jacobi
P2860
P2888
P356
10.1186/S40425-014-0027-Z
P577
2014-08-19T00:00:00Z
P5875
P6179
1025192663